$CAMT

AMIT RAFI sold $1.1M of CAMT

AMIT RAFI (Chief Executive Officer) sold 6,250 shares of CAMTEK LTD (CAMT) at $170.52 ($1.07M total) on 2026-08-13.

Original reporting
SEC EDGAR · AMIT RAFI
Published Aug 17, 2026, 11:57 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 17, 2026, 1:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CAMT
Neutral
medium confidence
Mentioned
$CAMT
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CAMTNeutralLow
01

Why it matters

Traders may monitor insider activity as a sentiment input, but this filing alone does not provide new guidance, contracts, litigation, or operational changes.

02

Market read

A new insider sale disclosure for CAMT is reported, with no accompanying fundamental catalyst in the provided text.

03

What to watch

The text does not state whether the sale was part of a 10b5-1 plan (it says 'No'), nor does it provide context like option exercises, tax withholding, or prior sale patterns.

Relevance 6/10Novelty 3/10Timing: SEC Form 4 filed 2026-08-17 (after-hours/filing time)

Background

The article is an SEC Form 4 insider transaction disclosure for CAMTEK (CAMT) by CEO Amit Rafi.

Company-level read

Ticker impact

$CAMTNeutralMedium confidence
Context

CAMTEK CEO Amit Rafi sold 6,250 shares in an open-market transaction valued at $1.07M, per a new SEC Form 4 filed today.

Expected impact

Likely limited near-term impact; any effect is more sentiment-driven than fundamental.

Evidence & confidence

This is a routine Form 4 open-market sale with no 10b5-1 plan stated and no accompanying company-specific operational news in the text.

Market effects

No sector-level signal is provided beyond a single insider sale.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs, so the market may overreact if it treats the sale as a bearish signal.

Key entities

  • CAMTEK LTD

    Company whose CEO insider sale is disclosed via SEC Form 4.

  • AMIT RAFI

    Chief Executive Officer who sold 6,250 shares at $170.52 per share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CAMTMed

CAMTEK LTD (CAMT): Financial results for FY

CAMTEK LTD (CAMT) furnished an SEC Form 6-K — earnings release. Yes ☐ No ☒ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. This Form 6-K, including all exhibits hereto, is hereby incorporated by r

$ESLTMed

Tue: Rate cut lifts market

The Tel Aviv Stock Exchange rose after the Bank of Israel cut interest rates to 3.25%. The Tel Aviv 35 Index gained 0.22%, while Dimri led gains with a 5.47% rise. OPC Energy fell 4.67%, the biggest decline. Key movers included Elbit Systems, Teva, and Ormat, which rose, and Camtek and Tower Semiconductor, which fell.

$CRDOMed

3 Under-the-Radar AI Stocks Wall Street Is Missing

Credo Technology (CRDO) reported Q4 2026 revenue of $437M, up 157% YoY, with guidance for 80% YoY growth in 2027. Astera Labs (ALAB) saw Q2 2026 revenue of $392.4M, up 104% YoY, with Scorpio X series ramping ahead of schedule. Camtek (CAMT) reported Q2 2026 revenue of $133.24M, up 8% YoY, with a strong order book extending into 2027.

$CAMTMedAI 8/10

Camtek (CAMT) Posted Record Q2 Revenue, Is The AI Upside Already Priced In?

Camtek (CAMT) reported record Q2 revenue of $600M+ year-to-date, driven by AI-related advanced packaging demand. The company issued upbeat Q3 guidance, contributing to a 17.55% monthly and 48.74% year-to-date stock price increase. Analysts debate its valuation, with some seeing it as 8.3% undervalued at $171.80, while others suggest it's overvalued based on discounted cash flow models.